Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 12:36 AM
NCT ID:
NCT00399867
Eligibility Criteria:
Inclusion Criteria:
* proven multiple myeloma,
* refractory to ongoing chemotherapy (bortezomib,
* bendamustin dexamethasone),
* measurable paraprotein,
* serum protein below 11 g/dl,
* age over 18 years,
* life expectancy greater 6 months,
* contraception in women,
* expected compliance,
* written consent
Exclusion Criteria:
* severe heart failure,
* not controlled hypertension or diabetes,
* risk factors for rhabdomyolysis,
* creatinin kinase below 30ml/min,
* active liver disease,
* myopathy,
* allergy to simvastatin,
* pregnancy,
* acute infectious disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00399867
Study Brief:
Protocol Section:
NCT00399867